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The stereotactic treatment planning has
two main aspects: the first one reflects
geometrical accuracy which must be achieved
during the whole procedure; the second one
takes into account a dosimetric accuracy of dose
distribution and absorbed dose calculations. An
analysis of geometrical, volume estimation and
dosimetric errors has been performed and
possible errors were estimated with the help of
phantoms and measurements.
Values observed in our experiments and
maximum values found in the literature,
presented in the tab.1, will be discussed in detail.
Quality assurance procedures for each step in the
treatment planning process, which will be outlined
as well, are absolutely necessary before starting
stereotactic treatments for estimation of
magnitude of possible errors and then periodical
checks are required to prove consistency with
original values.
Table 1: Sources of errors and accuracies in stereotactic treatment planning.
Source of error Geometrical accuracy Dosimetric accuracy
MR image distortions 0.5 (7) mm
CT image distortions 0.05 mm
Angiography image distortions 0.1 (5) mm
(analog)
Scanner transfer 0.1 (1) mm
Image fusion 0.5 (2) mm
Skull measurements 0.5 mm
Image definition 0.5 (1.5) mm
Tumour volume evaluation 5% -10% 1-3%
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The authors present the results
of treatment in 15 cases of melanoma malignum
chorioideae treated with brachytherapy using
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ruthenium plaque on the basis of ultrasonographic
and clinical evaluation.
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